Clinical Trial Update: Intravenous Plasma Treatment for Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating intravenous plasma treatment for idiopathic Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease Idiopathic

Drugs mentioned

• Intravenous Plasma Treatment

Snippet

Sponsor: The Neurology Center | Conditions: Idiopathic Parkinson Disease | EARLY_Phase 1 | Status: COMPLETED